The Investigational New Drug (IND) Workshop

Tuesday, April 10, 2018 - 1:00pm to 4:00pm

Trent Semans Center for Health Education - Great Hall

Add to calendar


Daniel Tonkin, PhD, RAC & Stephanie Pierce, PhD, RAC


Define an investigational drug, including off-label use of FDA approved drugs Provide guidance on determining when the IND regulations apply to research studies. Discuss the preparation and submission of IND applications to FDA Review maintenance and safety reporting requirements Encourage participant discussion of case scenarios


Nagorski, Susan

More Information